| Financial Year |
March 31 2023 |
| Monetary Funds |
195,499,183.52 |
| Held-for-trading Financial Assets |
58,689.29 |
| Notes Receivable |
23,821,418.91 |
| Accounts Receivable |
137,643,968.24 |
| Advances to Suppliers |
19,805,927.09 |
| Other Receivables |
4,323,580.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
435,694,370.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
68,324,238.17 |
| Total Current Assets |
916,719,433.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
919,305,937.56 |
| Under-construction Projects |
279,184,633.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
67,224,950.85 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
34,229,011.45 |
| Deferred Income Tax Assets |
10,647,386.07 |
| Other Non-Current Assets |
31,022,420.88 |
| Sub-Total of Non-Current Assets |
1,344,014,529.58 |
| Total Assets |
2,260,733,963.54 |
| Short-Term Loans |
62,564,702.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
24,896,607.20 |
| Accounts Payable |
142,665,979.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,871,218.68 |
| Taxes Payable |
15,020,309.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
133,533,861.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
35,001,043.69 |
| Other Current Liabilities |
19,821,378.41 |
| Sub-Total of Current Liabilities |
458,824,200.80 |
| Long-term Loans |
446,318,551.13 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,082,531.60 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
565,493,403.77 |
| Total Liabilities |
1,024,317,604.57 |
| Paid-In Capital(Or Share Stock) |
239,209,490.00 |
| Capital Surplus |
278,865,576.57 |
| Surplus Reserve |
112,952,940.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
605,388,351.69 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,236,416,358.97 |
| Owner's Equity（Stockholder's Equity） |
1,236,416,358.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,260,733,963.54 |
